Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $30.49 Analyst target: $62.73 Upside: 105.74%
Immunocore Holdings Limited, an advanced stage biotechnology company, develops immunotherapies for the treatment of cancer, infectious and autoimmune diseases. The company is headquartered in Abingdon, the United Kingdom.
See the full interactive analysis & chart →Informational only — not investment advice.